Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02340000 · ClinicalTrials.gov registry record · Phase 4
Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate
A Phase 4 study of Sinusitis, sponsored by Albany Medical College.
- Completed
- Registry status
- Phase 4
- Development phase
- 315
- Enrollment target
- 1
- Study location
NCT02340000: Completed Phase 4 study of Sinusitis, sponsored by Albany Medical College.
NCT02340000 is a Phase 4 study of Sinusitis that has completed, run by Albany Medical College. The registered enrollment target is 315 participants, above the 104-participant average among 12 other Sinusitis trials with a reported enrollment target (203% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02340000, a Phase 4 study of Sinusitis, has completed, sponsored by Albany Medical College.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 315 participants
- Enrollment target
- 1
- Study location
Study Summary
The aim is to determine if high-dose amoxicillin/clavulanate is more effective than standard-dose amoxicillin/clavulanate in treating acute bacterial sinusitis in adults seen at a primary care office.
Primary Outcome
rating of "a lot better" or "no symptoms"
Conditions Studied
Interventions
- DRUG standard dose amoxicillin/clavulanate
- DRUG high dose amoxicillin/clavulanate
Study Locations (1)
New York
- Albany Medical Center Internal Medicine and Pediatrics - Latham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 315 participants |
| Start Date | 2014-11-18 |
| Est. Completion | 2017-02-27 |
| Phase | Phase 4 |
What the finished NCT02340000 record still lists
NCT02340000 is an interventional study that assigns participants to a tested intervention. The registered 315 participants enrollment target is mid-sized for trials with a published cap, above the 104-participant average among 12 other Sinusitis trials with a reported enrollment target (203% higher).
The record links to 1 condition, with Sinusitis appearing as the primary indexed condition, and to 2 interventions - of which standard dose amoxicillin/clavulanate is the first listed.
NCT02340000 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT02340000 about?
NCT02340000 is a clinical study titled "Clinical Trial of the Treatment of Acute Sinusitis With Standard-dose Versus High-dose Amoxicillin/Clavulanate". The aim is to determine if high-dose amoxicillin/clavulanate is more effective than standard-dose amoxicillin/clavulanate in treating acute bacterial sinusitis in adults seen at a primary care office.
What is the current status of trial NCT02340000?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 315 participants. The study started on 2014-11-18. Estimated completion is 2017-02-27.
What conditions does trial NCT02340000 study?
This clinical trial studies the following conditions: Sinusitis.
What interventions are being tested in trial NCT02340000?
The interventions under investigation include: standard dose amoxicillin/clavulanate (DRUG), high dose amoxicillin/clavulanate (DRUG).
Who is sponsoring clinical trial NCT02340000?
This trial is sponsored by Albany Medical College, which has 52 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02340000 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Sinusitis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT02340000's enrollment target sits among peer trials
315 2nd of 12 the highest of 12 other Sinusitis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Sinusitis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Dupixent Study for Alternate Administration
ACTIVE NOT RECRUITING · Phase 4
-
How OMT Benefits Newly Diagnosed Patients With Respiratory Illness When Given Alongside Other Standard Care.
RECRUITING · NA
-
High Resolution Micro OCT Imaging
ACTIVE NOT RECRUITING
-
Reducing Antibiotic Use by Implementation of Stewardship in Primary and Urgent Care
ACTIVE NOT RECRUITING
-
A Study To Measure The Level Of Drug In Nasal Tissue And Blood After Taking A Single 2g Dose Or 500mg Tablets For Up To
COMPLETED · Phase 2
-
Near Infrared Transillumination of the Paranasal Sinuses
COMPLETED
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04812366 · 315 participants · Phase 2
Genomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer
- NCT05101460 · 315 participants
An All Comers Registry For Normothermic Ex Vivo Lung Perfusion (EVLP) as Assessment of Donor Lungs for Transplant
- NCT05897320 · 315 participants · Phase 3
A Study of Eptinezumab in Pediatric Participants With Episodic Migraine
- NCT06439082 · 315 participants · Phase 3
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI